Savara Pharmaceuticals
SVRA
#6615
Rank
โ‚ฌ0.52 B
Marketcap
3,07ย โ‚ฌ
Share price
-1.23%
Change (1 day)
-27.36%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ75.87 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.1 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ75.87 Million45.62%
2023 -โ‚ฌ52.1 Million43.38%
2022 -โ‚ฌ36.34 Million-11.31%
2021 -โ‚ฌ40.97 Million-13.3%
2020 -โ‚ฌ47.26 Million-36.53%
2019 -โ‚ฌ74.46 Million13.76%
2018 -โ‚ฌ65.45 Million105.54%
2017 -โ‚ฌ31.85 Million34.11%
2016 -โ‚ฌ23.75 Million-37.43%
2015 -โ‚ฌ37.95 Million38.81%
2014 -โ‚ฌ27.34 Million33.62%
2013 -โ‚ฌ20.46 Million38.49%
2012 -โ‚ฌ14.78 Million24.59%
2011 -โ‚ฌ11.86 Million-36.5%
2010 -โ‚ฌ18.68 Million-3.14%
2009 -โ‚ฌ19.28 Million-23.28%
2008 -โ‚ฌ25.13 Million8.52%
2007 -โ‚ฌ23.16 Million-34.14%
2006 -โ‚ฌ35.16 Million184.43%
2005 -โ‚ฌ12.37 Million90.75%
2004 -โ‚ฌ6.49 Million190.35%
2003 -โ‚ฌ2.24 Million11.64%
2002 -โ‚ฌ2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.3 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.12 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA